ADC Therapeutics SA (ADCT): Shares Outstanding

Annual figures by period end, from SEC filings.

125.75M
As of 2025-12-31
127.44M
As of 2026-06-30
+16.0%
3-year compound annual growth
2022-12-31: 80.64M2023-12-31: 82.29M2024-12-31: 98.86M2025-12-31: 125.75M125.75M
2022-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-31125.75M+27.2%2026-03-10, Balance as of period end
2024-12-3198.86M+20.1%2026-03-10, Balance as of period end
2023-12-3182.29M+2.0%2025-03-27, Balance as of period end
2022-12-3180.64Mn/a2024-03-13, Balance as of period end